Table 27 Chemical purity (%) of cagrilintide in cagrilintide and semaglutide coformulations formulated with hydroxypropyl cyclodextrins of varying type Concluding Remarks The results presented in table 26 show that in co-formulation 24 (HP-G-CD), high numbers of sub-visible particles were observed already at time zero, which preclude the use of HP-G-CD to co-formulate cagrilintide and semaglutide
Similar content being viewed by others Introduction Ulcerative colitis (UC), an inflammatory bowel disease (IBD), is a cryptogenic chronic disease that causes erosions or ulcers due to inflammation of the mucous membrane of the large intestine 1
10.1089/ars.2011.4391 [DOI] [PMC free article] [PubMed] [Google Scholar] Li B., Qiu B., Lee D.S.M., Walton Z.E., Ochocki J.D., Mathew L.K., Mancuso A., Gade T.P.F., Keith B., Nissim I., and Simon M.C
Management: Use saline spray before Semax to moisturize passages